Raal, Frederick J
Avasimibe, an ACAT inhibitor, enhances the lipid lowering effect of atorvastatin in subjects with homozygous familial hypercholesterolemia. [electronic resource]
- Atherosclerosis Dec 2003
- 273-9 p. digital
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
ISSN: 0021-9150
Standard No.: 10.1016/j.atherosclerosis.2003.07.011 doi
Subjects--Topical Terms: Acetamides Acetates--administration & dosage Administration, Oral Adolescent Adult Age Factors Atorvastatin Child Cross-Over Studies Dose-Response Relationship, Drug Double-Blind Method Drug Administration Schedule Drug Synergism Drug Therapy, Combination Enzyme Inhibitors--administration & dosage Female Follow-Up Studies Heptanoic Acids--administration & dosage Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors--administration & dosage Hyperlipoproteinemia Type II--diagnosis Lipoproteins, HDL--drug effects Lipoproteins, LDL--drug effects Male Middle Aged Multivariate Analysis Probability Pyrroles--administration & dosage Reference Values Risk Assessment Severity of Illness Index Sex Factors Sterol O-Acyltransferase--antagonists & inhibitors Sulfonamides Sulfonic Acids--administration & dosage Treatment Outcome Sterol O-Acyltransferase 2